Although it is the leading infectious cause of birth defects, patients and some doctors know little about cytomegalovirus.

- LIVTENCITY Is the First and Only Inhibitor of CMV-specific UL97 Protein Kinase Approved in China for the Treatment of Adults With Post-transplant CMV Infection/Disease Refractory* to Conventional ...

“Why didn’t anyone tell me about this virus?” is a frequent response I hear from parents upon learning their newborn is infected with cytomegalovirus or CMV. Although more than half of the U.S.

VANCOUVER, British Columbia—Cytomegalovirus (CMV) infection in kidney or kidney/pancreas transplant recipients occurs more frequently when alemtuzumab is used for induction instead of antithymocyte ...

Credit: Getty Images This review provides a concise overview of the epidemiology, etiology, history, diagnostic criteria, and management of CMV infection in solid organ transplant recipients.

Dr. Laura Gibson, UMass Chan Medical School associate professor of infectious disease and immunology PHOTO COURTESY OF UMASS MEMORIAL HEALTH Medical research and bedside patient care often exist in ...

With no vaccine available, early detection, hygiene practices, and public education are vital to prevent long-term disabilities caused by Human Cytomegalovirus in Kashmir’s children Dr Umer Majeed ...

At-risk patients, such as those with HIV or transplant recipients, could benefit from potentially life-saving study carried out by a University of Surrey led group of international researchers. The ...

CARROLLTON, Ga. - Visiting Children's Healthcare of Atlanta, Mason Barnes is a pretty typical 3-year-old, who just happens to be wearing two cochlear implants. "He wakes up in the morning and he says, ...